MATTHEW JAMES to Cost-Benefit Analysis
This is a "connection" page, showing publications MATTHEW JAMES has written about Cost-Benefit Analysis.
Connection Strength
0.052
-
Screening for chronic kidney disease in Canadian indigenous peoples is cost-effective. Kidney Int. 2017 07; 92(1):192-200.
Score: 0.028
-
Healthcare Costs Attributable to Hypertension: Canadian Population-Based Cohort Study. Hypertension. 2015 Sep; 66(3):502-8.
Score: 0.025